Bioxytran, Inc. (OTCQB: BIXT) announced on November 16, 2026, the immediate launch of its first two nutraceutical products, marking an expansion from its clinical-stage biotechnology pipeline into the consumer wellness market. The company introduced A-SUQAR and V-LO, which are available for purchase starting today at bioxytran.myshopify.com.
A-SUQAR is a supplement formulated to help maintain healthy blood sugar levels after meals. The product works by slowing the breakdown and absorption of dietary sugars in the intestine, with the stated goal of supporting healthy metabolism and balanced energy throughout the day. V-LO is a supplement designed to support the body's natural immune defenses, intended to help individuals stay strong and resilient through the seasons.
Both products are based on Bioxytran’s expertise in complex carbohydrate chemistry. According to the filing, the products are formulated with ingredients that are Generally Recognized as Safe (GRAS), are manufactured in a certified facility, and were tested by a third-party independent laboratory. The company notes that these statements have not been evaluated by the Food and Drug Administration, and the products are not intended to diagnose, treat, cure, or prevent any disease.
David Platt, Ph.D., the Chief Executive Officer of Bioxytran, stated in the press release that the launch is driven by a principle to apply rigorous scientific standards to everyday health. He noted that the company has held these products to the same diligence applied to its drug programs. The filing also includes standard forward-looking statements regarding the launch, availability, market acceptance, and potential benefits of the nutraceutical products, as well as risks related to manufacturing, supply, consumer demand, and regulatory requirements applicable to dietary supplements.